基于杜邦分析法的江苏恒瑞医药股份有限公司财务战略分析

本科论文AbstractIn China,with the rapid economic development,the pharmaceutical industry has beendeveloping with the economy,and the growth rate even exceeds the domestic economy.Inthe world,large pharmaceutical enterprises occupy the pharmaceutical market before Chinabecause of their advantages in time,scale,capital and so on.The current situation ofpharmaceutical enterprises in China is large number and small scale,which leads todisordered management,and most of them are not innovative drugs.It is urgent for Chinesepharmaceutical enterprises to transform into innovative pharmaceutical enterprises.This paper consists of five chapters:the first chapter is the introduction,which mainlyintroduces the research background,purpose and significance of this paper,as well as thedomestic and foreign research status,research content and methods.Then is the secondchapter related theory analysis,this article involves the theory of a general introduction,specific DuPont analysis of the basic introduction and DuPont analysis of the relevantindicators,followed by the introduction of the meaning and content of financial strategy.The third chapter is the financial strategy analysis of Hengrui pharmaceutical.This chapterfirst introduces the basic information of the company and the major events in thedevelopment process,then analyzes the basic indicators in DuPont analysis method in detail,and analyzes the company's financial strategy through indicators.The fourth chapter isbased on the analysis results of the financial indicators in the third chapter.It discusses theproblems of Hengrui pharmaceutical through DuPont analysis and the suggestions based onthese problems.The fifth chapter is the conclusion,which summarizes the whole researchand provides some suggestions for the financial strategy of the related enterprises.Key words:DuPont analysis;financial strategy;Heng Rui medicine